Join
Live feed
·
PRReleasevia Quantisnow
TriSalus Life Sciences Inc. logo

TriSalus Life Sciences Announces Publication Demonstrating Enhanced Delivery and Immune Activation with Nelitolimod Delivered with Pressure-Enabled Drug Delivery in Liver Tumor Models

ByQuantisnow·Wall Street's wire, on your screen.
TLSI· TriSalus Life Sciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track TLSI (TriSalus Life Sciences Inc.) and more on Quantisnow.